Search for: "Sanofi S A"
Results 141 - 160
of 933
Sorted by Relevance
|
Sort by Date
10 Dec 2013, 10:01 am
Per the EFF, Sanofi-Aventis backed down: “Under terms of Tuesday’s settlement, AcompliaReport.com keeps its domain name, as long as there is a disclaimer stating that the website is not associated with Sanofi-Aventis. [read post]
10 Nov 2017, 9:45 am
Sanofi made a validity challenge to Enbrel®’s patents easier. [read post]
25 Mar 2011, 8:26 am
How's that for adding insult to injury? [read post]
25 Mar 2011, 8:26 am
How's that for adding insult to injury? [read post]
31 Aug 2006, 6:15 pm
The judge said Sanofi had demonstrated that questions Apotex raised as to the validity and enforceability of its patent were without substantial merit and he also concluded Sanofi would suffer irreparable harm if Apotex were permitted to continue selling the generic while any detriment to Apotex was a result of the company's own calculated risk-taking. [read post]
22 Jul 2012, 6:40 am
Sanofi’s original patent on leflunomide expired in 2004. [read post]
5 Oct 2017, 11:24 am
"U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent": Brendan Pierson of Reuters has this report on a ruling that the U.S. [read post]
3 Aug 2008, 4:38 pm
" Sanofi had "raised substantial questions," including whether claim construction would go Novo's way. [read post]
12 Nov 2010, 5:16 am
The Deal Prof does a great job of plowing through Genzyme's old proxy statements to give us a deeper look at why Sanofi will be unlikely to do much to stop Genzyme from re-staggering its board should it want to.... [read post]
17 Feb 2007, 7:58 am
One of the biggest challenges was to prevent Sanofi's attorneys from slowing the case, the Stradling lawyers said. [read post]
Three Strikes, You’re Out!? Apotex’s Latest Attempt to Invalidate the PLAVIX® Patent Denied by USPTO
9 Jul 2010, 3:00 am
Strike 2: In August 2009 the USPTO ordered reexamination of Sanofi’s patent (U.S. 90/009,474) in response to Apotex’s request for reexamination. [read post]
27 Feb 2020, 10:25 am
Here, the listed patent at issue is US Patent 8,556,864 which covers the drive mechanism for Sanofi’s SoloSTAR Insulin Pen. [read post]
12 Sep 2007, 9:48 am
Inc. and sanofi-aventis U.S. [read post]
2 Jan 2008, 9:12 am
The primary focus of Grassley's letter is the FDA's review of Sanofi-Aventis' Study 3014, and the FDA's unprecedented reliance on adverse-events data collected in foreign countries for evidence of Ketek's safety when approving this antibiotic for sale in the U.S. [read post]
26 May 2023, 2:23 pm
Sanofi as an “endorsement of the Federal Circuit’s current interpretation and application of the enablement requirement, and maintenance of the status quo. [read post]
9 Jul 2016, 4:26 am
Before this FDA warning, Sanofi’s label in the United States indicated that a patient’s hair will generally grow back after completing the treatment. [read post]
21 Feb 2011, 2:11 am
For those of you looking for an example of a publicly traded contingent value right agreement, you can download the Genzyme/Sanofi CVR here. [read post]
19 Aug 2019, 11:39 am
Aug. 14, 2019) Judge Shipp (D.N.J.) upheld the validity of several claims of Sanofi’s patent, but found several claims invalid. [read post]
17 Feb 2011, 8:13 am
The Genzyme-Sanofi transaction is being structured as a tender offer with a back end short form merger (merger agreement). [read post]
13 Sep 2008, 4:35 am
According to Sanofi-Aventis' July 18 filing with the House clerk's office, the drugmaker's lobbying efforts were directed in part at follow-on biologics legislation. [read post]
